Home LiteratureArticle Details
PMID: 17928346 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Review

Viral and host factors in human respiratory syncytial virus pathogenesis.

Journal of virology ·Vol. 82 ·No. 5 ·2008-03-00 ·Pages 2040-55

Collins PL, Graham BS

Abstract

暂无摘要

MeSH Terms
Humans Respiratory Syncytial Virus Infections/immunology,physiopathology,virology Respiratory Syncytial Viruses/physiology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Collins Peter L
NIAID, NIH, 50 South Drive, MSC 8007, Bethesda, MD 20892, USA. pcollins@niaid.nih.gov
Graham Barney S
References (162)
162 references, click to expand
  1. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.
    J Gen Virol. 1997 Oct;78 ( Pt 10):2411-8 PMID: 9349459
  2. Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing.
    J Pediatr. 2001 Mar;138(3):311-7 PMID: 11241035
  3. Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.
    J Virol. 2005 Jul;79(14):9157-67 PMID: 15994810
  4. TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease.
    Dis Markers. 2006;22(5-6):303-8 PMID: 17264400
  5. Respiratory syncytial virus infections in previously healthy working adults.
    Clin Infect Dis. 2001 Sep 15;33(6):792-6 PMID: 11512084
  6. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.
    J Virol. 1987 Jun;61(6):1851-4 PMID: 3553614
  7. Neonatal adaptive immunity comes of age.
    Nat Rev Immunol. 2004 Jul;4(7):553-64 PMID: 15229474
  8. Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus.
    J Biol Chem. 2003 Nov 21;278(47):46854-61 PMID: 12952986
  9. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin.
    Am J Med. 2002 Jun 1;112(8):627-33 PMID: 12034412
  10. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages.
    Am Rev Respir Dis. 1989 Sep;140(3):771-7 PMID: 2476959
  11. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2006 Mar 15;173(6):639-43 PMID: 16387798
  12. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma.
    Proc Am Thorac Soc. 2005;2(2):157-61 PMID: 16113485
  13. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity.
    J Med Virol. 2000 Oct;62(2):267-77 PMID: 11002258
  14. Cytokines in severe respiratory syncytial virus bronchiolitis.
    Pediatr Pulmonol. 2002 Jun;33(6):449-52 PMID: 12001278
  15. Respiratory syncytial virus in healthy adults: the cost of a cold.
    J Clin Virol. 2003 May;27(1):14-21 PMID: 12727524
  16. The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.
    J Virol. 2002 Jun;76(12):6164-71 PMID: 12021350
  17. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.
    Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8996-9001 PMID: 15956195
  18. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity.
    J Pediatr. 1980 Feb;96(2):179-86 PMID: 6243354
  19. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates.
    J Infect Dis. 2003 Aug 1;188(3):433-9 PMID: 12870126
  20. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection.
    Am J Respir Crit Care Med. 2005 Jul 15;172(2):233-7 PMID: 15879412
  21. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.
    J Virol. 2006 May;80(10):5032-40 PMID: 16641294
  22. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.
    J Immunol. 2000 Dec 1;165(11):6487-95 PMID: 11086089
  23. Palivizumab in the prophylaxis of respiratory syncytial virus infection.
    Expert Rev Anti Infect Ther. 2005 Oct;3(5):719-26 PMID: 16207163
  24. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
    J Infect Dis. 2001 Dec 1;184(11):1374-9 PMID: 11709778
  25. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness.
    J Virol. 2005 Jul;79(14):9315-9 PMID: 15994826
  26. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons.
    J Virol. 1994 Jul;68(7):4538-46 PMID: 8207828
  27. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.
    Am J Respir Cell Mol Biol. 2006 Mar;34(3):320-9 PMID: 16284360
  28. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood.
    J Exp Med. 2002 Nov 18;196(10):1381-6 PMID: 12438429
  29. Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effect.
    J Virol. 1999 Oct;73(10):8384-92 PMID: 10482589
  30. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection.
    J Infect Dis. 2007 Jun 15;195(12):1779-88 PMID: 17492594
  31. A role for immune complexes in enhanced respiratory syncytial virus disease.
    J Exp Med. 2002 Sep 16;196(6):859-65 PMID: 12235218
  32. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus.
    J Virol. 2007 Jul;81(14):7786-800 PMID: 17494077
  33. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.
    J Virol. 2002 Jun;76(11):5654-66 PMID: 11991994
  34. Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity.
    Expert Opin Pharmacother. 2003 Oct;4(10):1801-8 PMID: 14521489
  35. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.
    Arch Dis Child. 2003 Oct;88(10):922-6 PMID: 14500316
  36. CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population.
    J Infect Dis. 2007 Jun 1;195(11):1618-24 PMID: 17471431
  37. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2006 Apr 15;173(8):871-6 PMID: 16456141
  38. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.
    J Virol. 2000 Nov;74(22):10508-13 PMID: 11044095
  39. Inhibition of airway Na+ transport by respiratory syncytial virus.
    J Virol. 2007 Apr;81(8):3714-20 PMID: 17287265
  40. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation.
    Clin Infect Dis. 2004 Jul 15;39(2):e17-20 PMID: 15307047
  41. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.
    N Engl J Med. 1988 Oct 27;319(17):1112-7 PMID: 3173442
  42. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
    J Infect Dis. 2005 Apr 1;191(7):1093-104 PMID: 15747245
  43. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.
    J Gen Virol. 2001 Dec;82(Pt 12):2881-2888 PMID: 11714962
  44. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells.
    Virology. 2004 Dec 20;330(2):384-97 PMID: 15567433
  45. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
    Pediatr Infect Dis J. 2003 May;22(5):394-405 PMID: 12792378
  46. Serum antibody decay in adults following natural respiratory syncytial virus infection.
    J Med Virol. 2006 Nov;78(11):1493-7 PMID: 16998887
  47. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.
    J Virol. 2005 Jan;79(2):1113-24 PMID: 15613339
  48. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis.
    J Allergy Clin Immunol. 2003 Jul;112(1):64-71 PMID: 12847481
  49. Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes.
    Hum Immunol. 2005 Jun;66(6):666-76 PMID: 15993712
  50. The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children.
    Curr Opin Allergy Clin Immunol. 2006 Feb;6(1):56-61 PMID: 16505613
  51. Latency and persistence of respiratory syncytial virus despite T cell immunity.
    Am J Respir Crit Care Med. 2004 Apr 1;169(7):801-5 PMID: 14742302
  52. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.
    J Virol. 2003 Aug;77(15):8426-39 PMID: 12857912
  53. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.
    N Engl J Med. 1981 Oct 8;305(15):841-6 PMID: 6168908
  54. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults.
    J Med Virol. 1999 Oct;59(2):221-6 PMID: 10459160
  55. The role of IFN in respiratory syncytial virus pathogenesis.
    J Immunol. 2002 Mar 15;168(6):2944-52 PMID: 11884466
  56. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy.
    Pediatr Allergy Immunol. 2002 Dec;13(6):386-93 PMID: 12485313
  57. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.
    Nat Immunol. 2000 Nov;1(5):398-401 PMID: 11062499
  58. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections.
    J Infect Dis. 2005 Apr 1;191(7):1105-15 PMID: 15747246
  59. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
    J Infect Dis. 1998 Dec;178(6):1555-61 PMID: 9815203
  60. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children.
    J Immunol. 2007 Sep 1;179(5):3171-7 PMID: 17709532
  61. Respiratory syncytial virus infections: recent prospects for control.
    Antiviral Res. 2006 Sep;71(2-3):379-90 PMID: 16806515
  62. Unravelling the complexities of respiratory syncytial virus RNA synthesis.
    J Gen Virol. 2006 Jul;87(Pt 7):1805-1821 PMID: 16760383
  63. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.
    J Immunol. 2006 Feb 1;176(3):1600-8 PMID: 16424189
  64. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.
    J Infect Dis. 2002 Apr 15;185(8):1011-8 PMID: 11930309
  65. Immunity to and frequency of reinfection with respiratory syncytial virus.
    J Infect Dis. 1991 Apr;163(4):693-8 PMID: 2010624
  66. The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection.
    Epidemiol Infect. 2005 Apr;133(2):279-89 PMID: 15816153
  67. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
    J Pediatr. 2007 Jul;151(1):34-42, 42.e1 PMID: 17586188
  68. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.
    Am J Respir Crit Care Med. 2005 Jan 15;171(2):137-41 PMID: 15516534
  69. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines.
    J Immunol. 2001 Oct 1;167(7):3910-8 PMID: 11564809
  70. Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance.
    Clin Immunol. 2007 Jun;123(3):252-7 PMID: 17449325
  71. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness.
    J Med Virol. 1978;3(2):91-100 PMID: 104004
  72. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.
    J Virol. 1999 Jul;73(7):5852-64 PMID: 10364337
  73. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
    J Med Virol. 1989 Jul;28(3):133-9 PMID: 2666570
  74. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis.
    Clin Exp Immunol. 2004 Jul;137(1):139-45 PMID: 15196254
  75. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth.
    J Virol. 2007 Feb;81(4):1786-95 PMID: 17151097
  76. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection.
    Pediatr Res. 1976 Jan;10(1):75-8 PMID: 1246465
  77. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.
    Int Immunol. 1992 Apr;4(4):493-500 PMID: 1591217
  78. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.
    J Pediatr. 1978 Jul;93(1):28-32 PMID: 206677
  79. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.
    J Virol. 2007 Apr;81(7):3428-36 PMID: 17251292
  80. Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells.
    Hum Immunol. 2006 Jan-Feb;67(1-2):33-42 PMID: 16698423
  81. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.
    J Infect Dis. 2007 Apr 15;195(8):1126-36 PMID: 17357048
  82. Respiratory syncytial virus load predicts disease severity in previously healthy infants.
    J Infect Dis. 2005 Jun 1;191(11):1861-8 PMID: 15871119
  83. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.
    Pediatrics. 1971 Nov;48(5):745-55 PMID: 4330595
  84. Haplotypes of surfactant protein C are associated with common paediatric lung diseases.
    Pediatr Allergy Immunol. 2006 Dec;17(8):572-7 PMID: 17121584
  85. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.
    J Virol. 2006 Jun;80(12):5854-61 PMID: 16731924
  86. Rhinovirus-associated hospitalizations in young children.
    J Infect Dis. 2007 Mar 15;195(6):773-81 PMID: 17299706
  87. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.
    J Virol. 1994 Aug;68(8):5321-5 PMID: 8035532
  88. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.
    Am J Respir Crit Care Med. 2003 Sep 15;168(6):633-9 PMID: 12773328
  89. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.
    J Infect Dis. 1994 Jun;169(6):1368-73 PMID: 8195619
  90. The histopathology of fatal untreated human respiratory syncytial virus infection.
    Mod Pathol. 2007 Jan;20(1):108-19 PMID: 17143259
  91. New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.
    Proc Am Thorac Soc. 2005;2(2):166-73 PMID: 16113487
  92. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    J Infect Dis. 1997 Dec;176(6):1428-36 PMID: 9395351
  93. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs.
    Am J Physiol Lung Cell Mol Physiol. 2002 Aug;283(2):L494-502 PMID: 12114213
  94. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.
    J Biol Chem. 2003 Dec 26;278(52):53035-44 PMID: 14565959
  95. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus.
    J Virol. 2005 May;79(9):5507-15 PMID: 15827165
  96. Viral infections, cytokine dysregulation and the origins of childhood asthma and allergic diseases.
    Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S170-6, discussion S174-5 PMID: 16378042
  97. Function of the respiratory syncytial virus small hydrophobic protein.
    J Virol. 2007 Aug;81(15):8361-6 PMID: 17494063
  98. Respiratory syncytial virus and parainfluenza virus.
    N Engl J Med. 2001 Jun 21;344(25):1917-28 PMID: 11419430
  99. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response.
    Am J Respir Crit Care Med. 1997 Jul;156(1):190-5 PMID: 9230746
  100. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines.
    J Virol. 2005 May;79(9):5353-62 PMID: 15827150
  101. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.
    Virus Res. 1988 Aug;11(1):1-15 PMID: 2845680
  102. Pathogen recognition and innate immunity.
    Cell. 2006 Feb 24;124(4):783-801 PMID: 16497588
  103. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion.
    Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9859-64 PMID: 11493675
  104. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile.
    J Immunol. 1998 May 15;160(10):4730-7 PMID: 9590218
  105. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.
    Eur J Immunol. 1997 Dec;27(12):3341-9 PMID: 9464822
  106. Coupled translation of the second open reading frame of M2 mRNA is sequence dependent and differs significantly within the subfamily Pneumovirinae.
    J Virol. 2007 Aug;81(16):8488-96 PMID: 17522208
  107. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.
    J Immunol. 1971 Jul;107(1):123-30 PMID: 5091954
  108. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis.
    Eur Respir J. 1999 Jul;14(1):139-43 PMID: 10489841
  109. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    J Exp Med. 1997 Aug 4;186(3):421-32 PMID: 9236194
  110. Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus.
    Infect Immun. 1975 Jul;12(1):62-8 PMID: 166929
  111. Effects of viral respiratory infections on lung development and childhood asthma.
    J Allergy Clin Immunol. 2005 Apr;115(4):668-74; quiz 675 PMID: 15805982
  112. Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections.
    Eur J Immunol. 2006 Jun;36(6):1434-42 PMID: 16708402
  113. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.
    N Engl J Med. 1979 Mar 8;300(10):530-4 PMID: 763253
  114. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.
    J Infect Dis. 2005 Apr 15;191(8):1225-32 PMID: 15776367
  115. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.
    Am J Pathol. 2006 Sep;169(3):977-86 PMID: 16936271
  116. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network.
    Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S188-92 PMID: 15577572
  117. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
    Pediatr Infect Dis J. 2006 May;25(5):410-4 PMID: 16645504
  118. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.
    J Clin Microbiol. 1986 Aug;24(2):197-202 PMID: 3755730
  119. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
    Virology. 2001 Oct 25;289(2):283-96 PMID: 11689051
  120. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children.
    Pediatr Infect Dis J. 1993 Sep;12(9):733-9 PMID: 8414800
  121. The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein.
    Vaccine. 2007 Jun 28;25(27):5025-33 PMID: 17544182
  122. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.
    Ann Intern Med. 1978 Feb;88(2):203-5 PMID: 415653
  123. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.
    Nat Med. 2002 Jan;8(1):54-60 PMID: 11786907
  124. Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.
    J Virol. 2004 Jun;78(11):6024-32 PMID: 15141000
  125. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells.
    Immunology. 2003 May;109(1):49-57 PMID: 12709017
  126. Modeling the structure of the respiratory syncytial virus small hydrophobic protein by silent-mutation analysis of global searching molecular dynamics.
    Protein Sci. 2003 Dec;12(12):2668-74 PMID: 14627728
  127. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease.
    J Infect Dis. 2004 Jun 1;189(11):2057-63 PMID: 15143473
  128. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein.
    Nat Immunol. 2001 Aug;2(8):732-8 PMID: 11477410
  129. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
    J Virol. 2005 Jun;79(11):6588-97 PMID: 15890897
  130. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells.
    J Immunol. 2005 Nov 1;175(9):5904-11 PMID: 16237083
  131. Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus.
    J Virol. 1988 Jul;62(7):2228-33 PMID: 3373568
  132. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.
    J Infect Dis. 2004 Jun 1;189(11):2047-56 PMID: 15143472
  133. Respiratory syncytial virus infection in elderly and high-risk adults.
    N Engl J Med. 2005 Apr 28;352(17):1749-59 PMID: 15858184
  134. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.
    J Virol. 2007 Feb;81(3):1401-11 PMID: 17108032
  135. Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma.
    BMC Pulm Med. 2007 May 11;7:6 PMID: 17498296
  136. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection.
    J Pediatr. 1992 Jan;120(1):28-32 PMID: 1731020
  137. Identification of a novel virulence factor in recombinant pneumonia virus of mice.
    J Virol. 2007 Sep;81(17):9490-501 PMID: 17567693
  138. Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication.
    J Virol. 2006 Jan;80(2):975-84 PMID: 16378999
  139. Suppression of pattern-recognition receptor TLR4 sensing does not alter lung responses to pneumovirus infection.
    Microbes Infect. 2006 Mar;8(3):621-7 PMID: 16458035
  140. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis.
    J Infect Dis. 2001 Aug 15;184(4):393-9 PMID: 11471095
  141. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.
    J Virol. 1999 Apr;73(4):2956-62 PMID: 10074145
  142. Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group.
    J Infect Dis. 1999 Jul;180(1):41-9 PMID: 10353859
  143. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11259-64 PMID: 10500164
  144. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection.
    J Allergy Clin Immunol. 2004 Jan;113(1):127-33 PMID: 14713917
  145. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact.
    J Virol. 2002 Feb;76(3):1163-70 PMID: 11773392
  146. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus.
    Eur J Immunol. 2004 Apr;34(4):1146-53 PMID: 15048726
  147. The pathogenesis of respiratory syncytial virus disease in childhood.
    Br Med Bull. 2002;61:13-28 PMID: 11997296
  148. Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus.
    Virology. 1997 Sep 1;235(2):342-51 PMID: 9281514
  149. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.
    J Virol. 1998 Jul;72(7):5707-16 PMID: 9621029
  150. Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus.
    J Gen Virol. 1993 Jul;74 ( Pt 7):1445-50 PMID: 8336126
  151. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.
    J Clin Invest. 1991 Sep;88(3):1026-33 PMID: 1909350
  152. Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity.
    Pediatr Res. 2002 Sep;52(3):363-7 PMID: 12193668
  153. An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection.
    Am J Hyg. 1961 Nov;74:234-48 PMID: 14453700
  154. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response.
    J Allergy Clin Immunol. 2005 Oct;116(4):805-11 PMID: 16210054
  155. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants.
    Eur J Pediatr. 2001 Feb;160(2):117-22 PMID: 11271383
  156. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.
    J Clin Invest. 1995 Nov;96(5):2445-53 PMID: 7593633
  157. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.
    J Virol. 1998 Apr;72(4):2871-80 PMID: 9525607
  158. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.
    Blood. 2007 Sep 1;110(5):1578-86 PMID: 17495130
  159. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation.
    Am J Respir Crit Care Med. 1999 Jun;159(6):1918-24 PMID: 10351940
  160. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.
    J Pediatr. 2003 Nov;143(5 Suppl):S112-7 PMID: 14615709
  161. Experimental respiratory syncytial virus infection of four species of primates.
    J Med Virol. 1977;1(3):157-62 PMID: 416176
  162. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.
    J Immunol. 1993 Aug 15;151(4):2032-40 PMID: 8345194
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
1098-5514
DOI
10.1128/JVI.01625-07
Email
pcollins@niaid.nih.gov
Published
2008-03-00
Epub
2007-00-10
Pages
2040-55
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC2258918
Subset
IM
Grants
Intramural NIH HHS · United States
External Links
PubMed source DOI: 10.1128/JVI.01625-07 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2